1,475
Participants
Start Date
November 30, 2020
Primary Completion Date
December 1, 2024
Study Completion Date
December 1, 2024
Vitamin D3
Half the subjects will be randomized to the low dose vitamin D therapy (400 IU/day), which will serve as the control group, and half to moderate (4,000 IU/day) or high (10,000 IU/day). Study participants will have the option between being randomized to the low versus moderate or the low versus high dose arms.
Rush University Medical Center, Chicago
University of Chicago, Chicago
Rush University Medical Center
OTHER
University of Chicago
OTHER